These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38797561)

  • 1. [Topical immunomodulators for persistent high‑risk human papillomavirus infection: experts consensus in China].
    Chen F; Qiu LH; Sui L; Hao M; Yang Q; Hu YJ; Meng YG; Xiang Y; Wang JL; Guo RX; Duan H; Li CZ; Liu HT; Liu J; Liu M; Wang LQ; Wang JD; Wang M; Wang YF; Xia BR; Xu CJ; Yao SZ; Zhang YZ; Zhang YQ; Zhao X; Lang JH; Di W
    Zhonghua Fu Chan Ke Za Zhi; 2024 May; 59(5):337-342. PubMed ID: 38797561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.
    Millikan RC
    J Natl Cancer Inst; 1994 Mar; 86(5):392-3. PubMed ID: 8308931
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of human papillomavirus testing after treatment for high-grade cervical dysplasia.
    Turner TB; Huh WK
    J Gynecol Oncol; 2016 Jan; 27(1):e9. PubMed ID: 26676385
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of high-grade cervical intraepithelial neoplasia (CIN 2/3) or cancer during follow-up of human papillomavirus (HPV) infection or CIN 1.
    Cestero RM
    Am J Obstet Gynecol; 2006 Nov; 195(5):1196-7. PubMed ID: 17074542
    [No Abstract]   [Full Text] [Related]  

  • 5. The evolution of cost-effective screening and prevention of cervical carcinoma: implications of the 2006 consensus guidelines and human papillomavirus vaccination.
    Monk BJ; Herzog TJ
    Am J Obstet Gynecol; 2007 Oct; 197(4):337-9. PubMed ID: 17904955
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccines against papillomavirus infections and disease.
    Villa LL
    Rev Chilena Infectol; 2006 Jun; 23(2):157-63. PubMed ID: 16721451
    [No Abstract]   [Full Text] [Related]  

  • 7. Human papillomavirus types and cervical cancer.
    Apgar BS
    Hosp Pract (1995); 1996 Feb; 31(2):39-40, 43. PubMed ID: 8592014
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of type-specific human papillomavirus infection among cytologically normal women.
    Hsing AW; Schiffman M; Zhang T; Greer CE; Chen CJ; You SL; Hsieh CY; Huang TW; Liaw KL; Manos M
    J Infect Dis; 1994 Aug; 170(2):498. PubMed ID: 8035046
    [No Abstract]   [Full Text] [Related]  

  • 9. [HIV, HPV and cervical pathology].
    Quéreux C; Bory JP
    Contracept Fertil Sex; 1997 Feb; 25(2):120-4. PubMed ID: 9116771
    [No Abstract]   [Full Text] [Related]  

  • 10. Human papillomavirus testing in cervical cancer screening.
    Franceschi S; Mahé C
    Br J Cancer; 2005 May; 92(9):1591-2. PubMed ID: 15870829
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiological investigation on the cervical health of lesbians in Beijing, China.
    Chen X; Yan H; Cao Y; Li S; Yang N; Li X
    J Int Med Res; 2020 Feb; 48(2):300060519889754. PubMed ID: 32054350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comments on the article by L.Sevcík, P.Koliba, et al: HPV infection and cervical intraepithelial neoplasia. Ces. Gynek. 68, 2003, no. 4, pg. 237-243].
    Ondrus J; Dvorák V
    Ceska Gynekol; 2004 Sep; 69(5):423-24; author reply 424-7. PubMed ID: 15645588
    [No Abstract]   [Full Text] [Related]  

  • 13. Early detection of cervical neoplasia: narrowing the cytohistologic divide.
    Bedrossian CW
    Int J Gynecol Pathol; 2003 Jan; 22(1):1-3. PubMed ID: 12496688
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methods of cervical cancer screening and facing new problems in China].
    Zhang WH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):881-4. PubMed ID: 19173985
    [No Abstract]   [Full Text] [Related]  

  • 15. [Human papillomavirus].
    Matsumoto K
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():345-9. PubMed ID: 20942076
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of tumor-related papillomavirus infection of the genitals in the genesis of background pathology of the ectocervix, dysplasia and preinvasive cancer of the cervix uteri].
    Maksimov SIa; Savicheva AM; Bashmakova MA; Shaimardanova GI; Shipitsina EV; Rybina EV
    Vopr Onkol; 1999; 45(6):627-9. PubMed ID: 10703510
    [No Abstract]   [Full Text] [Related]  

  • 17. HPV testing for cervical neoplasia.
    Carozzi F; Confortini M; Cecchini S; Ciatto S
    Acta Cytol; 2001; 45(4):659-61. PubMed ID: 11480738
    [No Abstract]   [Full Text] [Related]  

  • 18. Localisation of HIV-1 to human papillomavirus associated cervical lesions.
    Vernon SD; Zaki SR; Reeves WC
    Lancet; 1994 Oct; 344(8927):954-5. PubMed ID: 7934364
    [No Abstract]   [Full Text] [Related]  

  • 19. Medication use, medical conditions, and the risk of human papillomavirus infection and subsequent cervical intraepithelial neoplasia 3 among women with mild cytologic abnormalities.
    Wang SS; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):542-5. PubMed ID: 15734987
    [No Abstract]   [Full Text] [Related]  

  • 20. Testing for human papillomavirus in women with abnormal pap smear results.
    Sawaya GF; Smith-McCune K
    JAMA; 2002 Sep; 288(11):1350-1; author reply 1351-2. PubMed ID: 12234220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.